GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cengild Medical Bhd (XKLS:0243) » Definitions » ROCE %

Cengild Medical Bhd (XKLS:0243) ROCE % : 14.87% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cengild Medical Bhd ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Cengild Medical Bhd's annualized ROCE % for the quarter that ended in Mar. 2024 was 14.87%.


Cengild Medical Bhd ROCE % Historical Data

The historical data trend for Cengild Medical Bhd's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cengild Medical Bhd ROCE % Chart

Cengild Medical Bhd Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
ROCE %
Get a 7-Day Free Trial 9.16 20.71 42.59 18.14 15.87

Cengild Medical Bhd Quarterly Data
Jun18 Jun19 Jun20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.30 9.86 16.32 13.68 14.87

Cengild Medical Bhd ROCE % Calculation

Cengild Medical Bhd's annualized ROCE % for the fiscal year that ended in Jun. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2023 )  (A: Jun. 2022 )(A: Jun. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2023 )  (A: Jun. 2022 )(A: Jun. 2023 )
=18.108/( ( (119.544 - 11.661) + (131.729 - 11.395) )/ 2 )
=18.108/( (107.883+120.334)/ 2 )
=18.108/114.1085
=15.87 %

Cengild Medical Bhd's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=18.3/( ( (137.033 - 13.788) + (136.543 - 13.615) )/ 2 )
=18.3/( ( 123.245 + 122.928 )/ 2 )
=18.3/123.0865
=14.87 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cengild Medical Bhd  (XKLS:0243) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Cengild Medical Bhd ROCE % Related Terms

Thank you for viewing the detailed overview of Cengild Medical Bhd's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cengild Medical Bhd Business Description

Traded in Other Exchanges
N/A
Address
No.7, Jalan Kerinchi, Unit 2-3 & 2-4, Level 2, Nexus, Bangsar South, Kuala Lumpur, MYS, 59200
Cengild Medical Bhd is a healthcare service provider operating a medical centre specialising in the diagnosis and treatment of gastrointestinal related oncology and gynaecology services., liver diseases and obesity. The company operates in Malaysia and has two reportable segments, Consultant Services and Medical Management Services. A substantial portion of the overall revenue is generated from its Medical Management Services segment.

Cengild Medical Bhd Headlines

No Headlines